Exploring Cellular Interactions of Liposomes Using Protein Corona Fingerprints and Physicochemical Properties.

To control liposomes fate and transport upon contact with biofluids, it is essential to consider several parameters affecting the synthetic and biological identity of liposomes, as well as liposome-protein corona (PC) aspects. As a powerful tool in this data mining adventure, quantitative structure-activity relationship (QSAR) approach is used to correlate physicochemical properties of liposomes and their PC fingerprints to multiple quantified biological responses. In the present study, the relationship between cellular interactions of a set of structurally diverse liposomal formulations and their physicochemical and PC properties has been investigated via linear and nonlinear QSAR models. Significant parameters affecting cellular uptake and cell viability of liposomes in two important cancer cell lines (PC3 and HeLa) have been identified. The developed QSARs have the capacity to be implemented in advanced targeted delivery of liposomal drugs.

[1]  Andrew Emili,et al.  Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. , 2014, ACS nano.

[2]  T. Puzyn,et al.  Toward the development of "nano-QSARs": advances and challenges. , 2009, Small.

[3]  Morteza Mahmoudi,et al.  Personalized protein coronas: a "key" factor at the nanobiointerface. , 2014, Biomaterials science.

[4]  Raimo Hartmann,et al.  Temperature: the "ignored" factor at the NanoBio interface. , 2013, ACS nano.

[5]  Rasmus Bro,et al.  Variable selection in regression—a tutorial , 2010 .

[6]  Giulio Caracciolo,et al.  Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. , 2014, Nanoscale.

[7]  P. Gemperline.  Practical Guide To Chemometrics , 2006 .

[8]  P. Cullis,et al.  Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.

[9]  Stefan Tenzer,et al.  Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. , 2011, ACS nano.

[10]  Giulio Caracciolo,et al.  Evolution of the protein corona of lipid gene vectors as a function of plasma concentration. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[11]  David J. C. MacKay,et al.  A Practical Bayesian Framework for Backpropagation Networks , 1992, Neural Computation.

[12]  Giulio Caracciolo,et al.  Do plasma proteins distinguish between liposomes of varying charge density? , 2012, Journal of proteomics.

[13]  Gerard W. Doorley,et al.  Cellular binding of nanoparticles in the presence of serum proteins. , 2011, Chemical communications.

[14]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[15]  S. Provencher.  A constrained regularization method for inverting data represented by linear algebraic or integral equations , 1982 .

[16]  Giulio Caracciolo,et al.  Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery. , 2013, Langmuir : the ACS journal of surfaces and colloids.

[17]  Iseult Lynch,et al.  Protein-nanoparticle interactions: What does the cell see? , 2009, Nature nanotechnology.

[18]  Warren C. W. Chan,et al.  Understanding and Controlling the Interaction of Nanomaterials with Proteins in a Physiological Environment , 2012 .

[19]  Paola Gramatica,et al.  The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models , 2003 .

[20]  Kevin Braeckmans,et al.  Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge. , 2013, ACS nano.

[21]  G. Caracciolo,et al.  The liposome-protein corona in mice and humans and its implications for in vivo delivery. , 2014, Journal of materials chemistry. B.

[22]  W. Chan,et al.  Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties. , 2015, Nanoscale.

[23]  Kostas Kostarelos,et al.  Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. , 2011, Accounts of chemical research.

[24]  G. Caracciolo,et al.  The biomolecular corona of nanoparticles in circulating biological media. , 2015, Nanoscale.

[25]  William B. Smith,et al.  Selective inhibition of BET bromodomains , 2010, Nature.

[26]  Stefan Tenzer,et al.  Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.

[27]  Martin Lundqvist,et al.  Nanoparticles: Tracking protein corona over time. , 2013, Nature nanotechnology.

[28]  Paola Gramatica,et al.  Principles of QSAR models validation: internal and external , 2007 .

[29]  Giulio Caracciolo,et al.  Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[30]  Iseult Lynch,et al.  What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.

[31]  Ka-Ho Leung,et al.  Antagonizing STAT3 dimerization with a rhodium(III) complex. , 2014, Angewandte Chemie.

[32]  Kenneth A. Dawson,et al.  Protein–Nanoparticle Interactions , 2008, Nano-Enabled Medical Applications.